The U.S. vaping industry is on the cusp of monumental change. Following detailed reports by the Wall Street Journal and Reuters, FDA has formally announced its intention to evaluate a possible overhaul of the PMTA framework, including new rulemaking to replace the existing system.
In this episode of RegWatch, tobacco control policy expert Cliff Douglas examines the developments driving the shift: mounting legal pressure, new CTP Director Bret Koplow’s embrace of harm reduction, and FDA commissioner nominee Dr. Heidi Overton’s defense of flavored vape authorizations.
With youth vaping sharply down and an enormous illicit market operating outside FDA oversight, the case for change is hard to ignore. But Douglas warns that faster approvals alone won’t help smokers who still misunderstand the risks of safer nicotine.
Is FDA about to rewrite the rules governing nicotine vapes?
Find out. Only on RegWatch by RegulatorWatch.com.
Released: October 7, 2026
Produced by: Brent Stafford
This episode is supported by DEMAND VAPE.
CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser
#RegWatch #VapeNews
Want More Investigative Content?
